• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢健康型肥胖表型是否能保护 III 级肥胖成年人免受与骨代谢相关的生化改变的影响?

Does the Metabolically Healthy Obese Phenotype Protect Adults with Class III Obesity from Biochemical Alterations Related to Bone Metabolism?

机构信息

Postgraduate Program, Nutritional Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21.941-902, Brazil.

Center for Research on Micronutrients (NPqM), Institute of NutritionJosué de Castro of UFRJ, Rio de Janeiro 21.941-902, Brazil.

出版信息

Nutrients. 2019 Sep 6;11(9):2125. doi: 10.3390/nu11092125.

DOI:10.3390/nu11092125
PMID:31489911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6771134/
Abstract

Obesity negatively affects the relationship between markers and micronutrients of bone metabolism. Testing the hypothesis that the metabolically healthy obese phenotype might be protected by those alterations was the aim of this study. A cross-sectional study was carried out in adults with class III obesity classified in Metabolically Healthy Obese (MHO) and Metabolically Unhealthy Obese (MUHO), according to the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP ATP III) criteria. Anthropometric, biochemical, and clinical variables were analyzed for sample characterization. To evaluate bone metabolism, markers (alkaline phosphatase and parathyroid hormone-PTH) and related nutrients (vitamin D, vitamin B12, calcium, phosphorus, magnesium, potassium and zinc) were analyzed. A total of 223 adults with class III obesity aged 41.20 ± 10.15 years were included. The MHO phenotype was identified in 32.73% of the sample. After logistic regression, it was observed that inadequacies of calcium (OR: 4.11; 95% CI: 2.33-6.66), phosphorus (OR: 3.03; 95% CI: 1.98-5.79), vitamin D (OR: 5.01; 95% CI: 2.92-6.71) and PTH (OR: 5.45; 95% CI: 4.49-6.74) were significantly higher in the MUHO group compared to the MHO Group. This study showed that the MHO phenotype does not protect adults from alterations in markers and micronutrients of bone metabolism. However, the MUHO phenotype presents a higher risk for alterations related to bone metabolism, which can favor the emergence of metabolic bone diseases.

摘要

肥胖会对骨代谢标志物和微量营养素之间的关系产生负面影响。本研究旨在检验“代谢健康型肥胖表型可能受到这些改变保护”的假说。这项横断面研究纳入了根据美国国家胆固醇教育计划专家委员会(NCEP ATP III)标准被分类为代谢健康型肥胖(MHO)和代谢不健康型肥胖(MUHO)的 III 级肥胖成年人。分析了人体测量学、生化和临床变量以进行样本特征描述。为了评估骨代谢,分析了标志物(碱性磷酸酶和甲状旁腺激素-PTH)和相关营养素(维生素 D、维生素 B12、钙、磷、镁、钾和锌)。共纳入了 223 名年龄为 41.20±10.15 岁的 III 级肥胖成年人。在该样本中,有 32.73%的人表现出 MHO 表型。经过逻辑回归分析,发现钙(OR:4.11;95%CI:2.33-6.66)、磷(OR:3.03;95%CI:1.98-5.79)、维生素 D(OR:5.01;95%CI:2.92-6.71)和 PTH(OR:5.45;95%CI:4.49-6.74)的不足在 MUHO 组中明显高于 MHO 组。本研究表明,MHO 表型并不能使成年人免受骨代谢标志物和微量营养素变化的影响。然而,MUHO 表型发生与骨代谢相关的变化的风险更高,这可能有利于代谢性骨病的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e55/6771134/66df5e32f4a2/nutrients-11-02125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e55/6771134/5c5db386cf3f/nutrients-11-02125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e55/6771134/66df5e32f4a2/nutrients-11-02125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e55/6771134/5c5db386cf3f/nutrients-11-02125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e55/6771134/66df5e32f4a2/nutrients-11-02125-g002.jpg

相似文献

1
Does the Metabolically Healthy Obese Phenotype Protect Adults with Class III Obesity from Biochemical Alterations Related to Bone Metabolism?代谢健康型肥胖表型是否能保护 III 级肥胖成年人免受与骨代谢相关的生化改变的影响?
Nutrients. 2019 Sep 6;11(9):2125. doi: 10.3390/nu11092125.
2
Metabolically healthy/unhealthy components may modify bone mineral density in obese people.代谢健康/不健康成分可能会改变肥胖人群的骨密度。
Arch Osteoporos. 2017 Oct 29;12(1):95. doi: 10.1007/s11657-017-0381-9.
3
Clinic, Anthropometric And Metabolic Changes In Adults With Class III Obesity Classified As Metabolically Healthy And Metabolically Unhealthy.肥胖III级成年人群中代谢健康型与代谢非健康型的临床、人体测量及代谢变化
Diabetes Metab Syndr Obes. 2019 Nov 27;12:2419-2431. doi: 10.2147/DMSO.S210616. eCollection 2019.
4
Can bone-regulating hormones and nutrients help characterize the metabolically healthy obese phenotype.骨调节激素和营养物质能否有助于表征代谢健康的肥胖表型?
Nutr Health. 2018 Sep;24(3):153-162. doi: 10.1177/0260106018777336. Epub 2018 Jun 27.
5
Effectiveness of vitamin D therapy in improving metabolomic biomarkers in obesity phenotypes: Two randomized clinical trials.维生素 D 疗法在改善肥胖表型代谢组学生物标志物中的有效性:两项随机临床试验。
Int J Obes (Lond). 2018 Oct;42(10):1782-1796. doi: 10.1038/s41366-018-0107-0. Epub 2018 Jun 11.
6
Vitamin D status is not related to insulin resistance in different phenotypes of moderate obesity.维生素D状态与中度肥胖不同表型中的胰岛素抵抗无关。
Appl Physiol Nutr Metab. 2017 Apr;42(4):438-442. doi: 10.1139/apnm-2016-0298. Epub 2017 Jan 3.
7
Evaluation of Liver Metabolism Biomarkers in Metabolic Associated Fatty Liver Disease According to Obesity Phenotype.基于肥胖表型评估代谢相关脂肪性肝病的肝脏代谢生物标志物。
J Am Nutr Assoc. 2023 Feb;42(2):140-147. doi: 10.1080/07315724.2021.2007427. Epub 2022 Feb 15.
8
No Difference in Lactoferrin Levels between Metabolically Healthy and Unhealthy Obese Women.肥胖的代谢健康与不健康女性之间乳铁蛋白水平无差异。
Nutrients. 2019 Aug 22;11(9):1976. doi: 10.3390/nu11091976.
9
Metabolically healthy obesity, vitamin D, and all-cause and cardiometabolic mortality risk in NHANES III.代谢健康型肥胖、维生素 D 与 NHANES III 研究中的全因和心血管代谢死亡风险
Clin Nutr. 2019 Apr;38(2):820-828. doi: 10.1016/j.clnu.2018.02.025. Epub 2018 Mar 2.
10
Predictors of incident obesity phenotype in nonobese healthy adults.非肥胖健康成年人中肥胖表型发生的预测因素。
Eur J Clin Invest. 2017 May;47(5):357-365. doi: 10.1111/eci.12743. Epub 2017 Apr 5.

引用本文的文献

1
Healthy eating index and bone health markers in adults with metabolically healthy and unhealthy obese phenotypes.具有代谢健康和不健康肥胖表型的成年人的健康饮食指数与骨骼健康标志物
Hum Nutr Metab. 2023 Jun;32:200186. doi: 10.1016/j.hnm.2023.200186. Epub 2023 Feb 21.
2
Chromium nanoparticles improve bone turnover regulation in rats fed a high-fat, low-fibre diet.铬纳米粒子改善高脂肪、低纤维饮食喂养大鼠的骨转换调节。
PLoS One. 2024 May 8;19(5):e0300292. doi: 10.1371/journal.pone.0300292. eCollection 2024.
3
Fat as a Friend or Foe of the Bone.

本文引用的文献

1
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病 (NAFLD) 中维生素 A 代谢紊乱。
Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029.
2
Vitamin D in obesity.肥胖中的维生素D
Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):389-394. doi: 10.1097/MED.0000000000000371.
3
Prevalence of Metabolically Healthy Obesity (MHO) and its relation with incidence of metabolic syndrome, hypertension and type 2 Diabetes amongst individuals aged over 20 years in Ahvaz: A 5 Year cohort Study (2009-2014).
脂肪:骨骼的朋友还是敌人?
Curr Osteoporos Rep. 2024 Apr;22(2):245-256. doi: 10.1007/s11914-024-00864-4. Epub 2024 Feb 28.
4
From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity Populations: Decreased Bone Turnover Bioactivity.从代谢健康型肥胖到代谢不健康型肥胖人群:骨转换生物活性降低。
Diabetes Metab Syndr Obes. 2023 Nov 16;16:3657-3667. doi: 10.2147/DMSO.S431194. eCollection 2023.
5
Relationship Between Zinc, Selenium, and Magnesium Status and Markers of Metabolically Healthy and Unhealthy Obesity Phenotypes.锌、硒、镁状态与代谢健康型和代谢不健康型肥胖表型标志物之间的关系
Biol Trace Elem Res. 2024 Aug;202(8):3449-3464. doi: 10.1007/s12011-023-03938-z. Epub 2023 Nov 14.
6
Understanding the Consequences of Fatty Bone and Fatty Muscle: How the Osteosarcopenic Adiposity Phenotype Uncovers the Deterioration of Body Composition.了解脂肪骨和脂肪肌肉的后果:骨肌减少性肥胖表型如何揭示身体成分的恶化。
Metabolites. 2023 Oct 7;13(10):1056. doi: 10.3390/metabo13101056.
7
A Systematic Review and Meta-Analysis of Vitamin D Status of Patients with Severe Obesity in Various Regions Worldwide.一项对全球不同地区重度肥胖患者维生素 D 状况的系统评价和荟萃分析。
Obes Facts. 2023;16(6):519-539. doi: 10.1159/000533828. Epub 2023 Aug 28.
8
Obesity and Skeletal Fragility.肥胖与骨骼脆弱
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e466-e477. doi: 10.1210/clinem/dgad415.
9
In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength and Low Bone Turnover.在肥胖男性中,2 型糖尿病与较差的小梁微结构和骨强度以及较低的骨转换有关。
J Clin Endocrinol Metab. 2021 Apr 23;106(5):1362-1376. doi: 10.1210/clinem/dgab061.
10
Obesity and Bone Health: A Complex Link.肥胖与骨骼健康:复杂的联系。
Front Cell Dev Biol. 2020 Dec 21;8:600181. doi: 10.3389/fcell.2020.600181. eCollection 2020.
阿瓦士20岁以上人群中代谢健康型肥胖(MHO)的患病率及其与代谢综合征、高血压和2型糖尿病发病率的关系:一项5年队列研究(2009 - 2014年)
Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S1037-S1040. doi: 10.1016/j.dsx.2017.07.036. Epub 2017 Jul 27.
4
Calcium and vitamin-D deficiency marginally impairs fracture healing but aggravates posttraumatic bone loss in osteoporotic mice.钙和维生素 D 缺乏轻微地损害骨折愈合,但加重骨质疏松症小鼠创伤后骨丢失。
Sci Rep. 2017 Aug 3;7(1):7223. doi: 10.1038/s41598-017-07511-2.
5
Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity.极重度肥胖与非酒精性脂肪性肝病和维生素 D 营养状况的关系。
Can J Gastroenterol Hepatol. 2017;2017:9456897. doi: 10.1155/2017/9456897. Epub 2017 Jun 8.
6
Influence of the definition of "metabolically healthy obesity" on the progression of coronary artery calcification.“代谢健康型肥胖”的定义对冠状动脉钙化进展的影响。
PLoS One. 2017 Jun 2;12(6):e0178741. doi: 10.1371/journal.pone.0178741. eCollection 2017.
7
Longitudinal Associations Between Vitamin D Metabolites and Sarcopenia in Older Australian men: The Concord Health and Aging in Men Project.澳大利亚老年男性维生素D代谢物与肌肉减少症的纵向关联:男性健康与衰老协和项目
J Gerontol A Biol Sci Med Sci. 2017 Dec 12;73(1):131-138. doi: 10.1093/gerona/glx086.
8
Associations between obesity and the radiographic phenotype in knee osteoarthritis.肥胖与膝骨关节炎的影像学表型之间的关联。
Turk J Med Sci. 2017 Apr 18;47(2):424-429. doi: 10.3906/sag-1512-26.
9
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.原发性甲状旁腺功能亢进症中骨转换与左心室功能的关系:EPATH试验
PLoS One. 2017 Apr 13;12(4):e0173799. doi: 10.1371/journal.pone.0173799. eCollection 2017.
10
Osteoporosis, obesity, and sarcopenia on abdominal CT: a review of epidemiology, diagnostic criteria, and management strategies for the reporting radiologist.腹部 CT 中的骨质疏松症、肥胖症和肌肉减少症:报告放射科医师的流行病学、诊断标准和管理策略综述。
Abdom Radiol (NY). 2017 Sep;42(9):2376-2386. doi: 10.1007/s00261-017-1124-5.